Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

Cancel

BSE Code : 524404 | NSE Symbol : MARKSANS | ISIN : INE750C01026 | Industry : Pharmaceuticals - Indian - Formulations |

(08-Aug-25 11:29) Marksans Pharma’s arm gets USFDA nod for Omeprazole 20 mg OTC tablets
(25-Jul-25 10:49) Marksans Pharma schedules board meeting
(11-Jul-25 17:41) Marksans Pharma AGM scheduled
(11-Jul-25 14:52) Marksans Pharma fixes record date for final dividend
(30-Jun-25 12:56) Time-Cap Laboratories successfully concludes USFDA inspection
(30-Jun-25 12:58) Marksans Pharma rises after subsidiary gets EIR for New York-based facility from US FDA
(19-Jun-25 10:04) Marksans Pharma’s UK arm gets marketing nod for Oxybutynin Oral solution from UKMHRA
(30-May-25 09:33) Marksans Pharma gets regulatory nod for marketing type-2 diabetes medication in UK
(30-May-25 09:13) Relonchem receives marketing authorization for Metformin Hydrochloride 500mg/ 5 ml Oral Solution in UK
(20-May-25 12:49) Board of Marksans Pharma recommends final dividend

1 2 3 4 5 6 7 8 9 10

Marksans Pharma Ltd